Ulcerative Colitis

The median 12-month risk of clinical relapse in patients with MES 1 was 28.7%, while the estimated annual risk of clinical relapse in patients with a MES 0 was 13.7%.

During the induction period, patients in the treatment group had higher incidences of infections and serious infectious compared to placebo.

New recommendations support the use of probiotics for preterm and low birthweight infants to prevent mortality and necrotizing enterocolitis.

In recent years, ustekinumab and tofacitinib have both been effective in treating ulcerative colitis.

Researchers are continuing to learn how the COVID-19 virus will effect patients with inflammatory bowel disease.

In an international survey, investigators discover women are more likely to suffer from a FGID than men.

Both inflammatory bowel disease and celiac disease share similar risk factors.

Individuals who commonly eat popcorn and drink milk have smaller odds of developing IBD.